$LEG

GLASSMAN KARL G sold (to issuer) 543,347 shares of LEG (indirect holdings)

GLASSMAN KARL G (President and CEO) sold (to issuer) 543,347 indirectly-held shares of LEGGETT & PLATT INC (LEG) across 2 trades on 2026-08-26.

Original reporting
SEC EDGAR · GLASSMAN KARL G
Published Aug 27, 2026, 6:51 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 27, 2026, 6:57 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LEG
Bearish
medium confidence
Mentioned
$LEG
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LEGBearishLow
01

Why it matters

The market may view the complete divestiture as a negative signal, prompting short interest.

02

Market read

Primary insider sell; modest materiality; limited broader market effect.

03

What to watch

No 10b5‑1 plan was used; the sale may have been pre‑planned and unrelated to performance.

Relevance 5/10Novelty 5/10Timing: today

Background

Form 4 filings disclose insider transactions; a CEO exiting his entire stake is noteworthy.

Company-level read

Ticker impact

$LEGBearishMedium confidence
Context

CEO Karl G. Glassman sold 543,347 shares, reducing his stake to zero.

Expected impact

Possible short-term downside as market digests the full insider exit.

Evidence & confidence

A C‑suite insider disposing of a large position is material news; however, the transaction size is modest relative to market cap.

Market effects

Minimal impact on the broader furniture components sector.

Limited to U.S. investors tracking Leggett & Platt.

Low

Counterpoint

The sell could be a personal liquidity need, not a reflection on company fundamentals.

Key entities

  • Karl G. Glassman

    President and CEO of Leggett & Platt

  • Leggett & Platt Inc.

    U.S. manufacturer of engineered components

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SGIMedAI 9/10

Somnigroup Completes Combination with Leggett & Platt

Somnigroup (SGI) completed its acquisition of Leggett & Platt, valued at $2.3B. The deal reduces Somnigroup's net leverage to 2.8x EBITDA and upsizes synergy targets to $75M annually. Leggett & Platt shareholders receive 0.1455 SGI shares per share. The combined company operates 170+ facilities across 37 countries. Somnigroup will host a business update call on September 2, 2026.

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).